Pretreatment with Huperzine A protects acetylcholinesterase in the rat brain against Inhibition by VX and Russian VX
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60162694%3AG44__%2F09%3A00002131" target="_blank" >RIV/60162694:G44__/09:00002131 - isvavai.cz</a>
Výsledek na webu
—
DOI - Digital Object Identifier
—
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Pretreatment with Huperzine A protects acetylcholinesterase in the rat brain against Inhibition by VX and Russian VX
Popis výsledku v původním jazyce
Organophosphate nerve agents are still considered as potential threats in both military and terrorism situations. They are potent irreversible inhibitors of acetylcholinesterase in central and also in peripheral compartment. Huperzine A (Hup A) is a reversible AChE inhibitor that crosses the blood-brain barrier. It is presently approved for human use or is in course of clinical trials for the treatment of Alzheimer's disease. This compound has also been successfully tested for pretreatment of organophosphate poisoning. In this study Hup A was tested as a prophylaxis against two V-nerve agents (VX and Russian VX). According to the obtained results, Hup A was able to partially protect AChE in the blood, diaphragm and brain against inhibition caused by Russian VX and VX.
Název v anglickém jazyce
Pretreatment with Huperzine A protects acetylcholinesterase in the rat brain against Inhibition by VX and Russian VX
Popis výsledku anglicky
Organophosphate nerve agents are still considered as potential threats in both military and terrorism situations. They are potent irreversible inhibitors of acetylcholinesterase in central and also in peripheral compartment. Huperzine A (Hup A) is a reversible AChE inhibitor that crosses the blood-brain barrier. It is presently approved for human use or is in course of clinical trials for the treatment of Alzheimer's disease. This compound has also been successfully tested for pretreatment of organophosphate poisoning. In this study Hup A was tested as a prophylaxis against two V-nerve agents (VX and Russian VX). According to the obtained results, Hup A was able to partially protect AChE in the blood, diaphragm and brain against inhibition caused by Russian VX and VX.
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FP - Ostatní lékařské obory
OECD FORD obor
—
Návaznosti výsledku
Projekt
<a href="/cs/project/OPUOFVZ200604" target="_blank" >OPUOFVZ200604: INDIKÁTORY - Biologické indikátory ionizujícího záření</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2009
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Letters in Drug Design and Discovery
ISSN
1570-1808
e-ISSN
—
Svazek periodika
6
Číslo periodika v rámci svazku
8
Stát vydavatele periodika
AE - Spojené arabské emiráty
Počet stran výsledku
5
Strana od-do
—
Kód UT WoS článku
000271393100002
EID výsledku v databázi Scopus
—